Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jill A Gallaher

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Scientific Reports|February 22, 2019
The impact of proliferation-migration tradeoffs on phenotypic evolution in cancerJill A Gallaher, Joel S Brown, Alexander R A Anderson
Medrxiv : the Preprint Server for Health Sciences|July 14, 2025
PSA/testosterone ratio as a potential biomarker to identify early progressors of adaptive therapy in metastatic castration sensitive prostate cancerJill A Gallaher, Robert A Gatenby, Joel S Brown, et al.
Cancer Research|February 1, 2018
Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer TherapiesJill A Gallaher, Pedro M Enriquez-Navas, Kimberly A Luddy, et al.
Scientific Reports|March 12, 2021
Cycling hypoxia selects for constitutive HIF stabilizationMariyah Pressley, Jill A Gallaher, Joel S Brown, et al.
Plos Computational Biology|February 27, 2020
From cells to tissue: How cell scale heterogeneity impacts glioblastoma growth and treatment responseJill A Gallaher, Susan C Massey, Andrea Hawkins-Daarud, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Scientific Reports|February 22, 2019
The impact of proliferation-migration tradeoffs on phenotypic evolution in cancerJill A Gallaher, Joel S Brown, Alexander R A Anderson
Medrxiv : the Preprint Server for Health Sciences|July 14, 2025
PSA/testosterone ratio as a potential biomarker to identify early progressors of adaptive therapy in metastatic castration sensitive prostate cancerJill A Gallaher, Robert A Gatenby, Joel S Brown, et al.
Cancer Research|February 1, 2018
Spatial Heterogeneity and Evolutionary Dynamics Modulate Time to Recurrence in Continuous and Adaptive Cancer TherapiesJill A Gallaher, Pedro M Enriquez-Navas, Kimberly A Luddy, et al.
Scientific Reports|March 12, 2021
Cycling hypoxia selects for constitutive HIF stabilizationMariyah Pressley, Jill A Gallaher, Joel S Brown, et al.
Plos Computational Biology|February 27, 2020
From cells to tissue: How cell scale heterogeneity impacts glioblastoma growth and treatment responseJill A Gallaher, Susan C Massey, Andrea Hawkins-Daarud, et al.
Pageof 1